Authors' response
- Vidya Navaratnam1,2,
- Kate M Fleming2,
- Joe West2,3,
- C J P Smith2,
- R G Jenkins1,
- Andrew W Fogarty1,2,
- Richard Hubbard1,2
- 1Nottingham Respiratory Biomedical Research Unit, University of Nottingham, Nottingham, UK
- 2Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
- 3Nottingham Digestive Diseases Biomedical Research Unit, University of Nottingham, Nottingham, UK
- Correspondence to Dr Vidya Navaratnam, Respiratory Medicine-Epidemiology, University of Nottingham, Clinical Sciences Building, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; vidya.navaratnam{at}nottingham.ac.uk
- Accepted 5 August 2011
- Published Online First 7 September 2011
- Clinical epidemiology
- drug induced lung disease
- interstitial fibrosis
- occupational lung disease
- histology/cytology
- COPD pathology
- asthma epidemiology
- COPD epidemiology
- allergic alveolitis
- allergic lung disease
- asthma
- sarcoidosis
We thank Drs Barber and Fishwick for their interest in our paper and would like to briefly respond to their comments.1 Our paper describes a pragmatic epidemiological study with individuals who had an underlying diagnosis of idiopathic pulmonary fibrosis clinical syndrome (IPF-CS).2 …
